Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
GEORGE M JENKINS Insider Profile
4 Followers
GEORGE M JENKINS, Director at Palvella Therapeutics, holds 191.70K shares in Palvella Therapeutics (Ticker: PVLA). Most recently, GEORGE M JENKINS Bought $4,000 shares of Palvella Therapeutics on Dec 19, 2024 for an estimated value of 51.72K.
GEORGE M JENKINS has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of GEORGE M JENKINS's holdings
Insider Roles
Director
Roles that GEORGE M JENKINS holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by GEORGE M JENKINS
GEORGE M JENKINS's Trading History
List of latest transactions for each holding click on a transaction to see GEORGE M JENKINS's performance on stock
You May Also Like
GEORGE M JENKINS insider profile FAQ
What is the percentage of profitable transactions made by GEORGE M JENKINS?
The percentage of profitable transactions made by GEORGE M JENKINS is ―.
What is the average return per transaction made by GEORGE M JENKINS?
The average return per transaction made by GEORGE M JENKINS is ―.
What stocks does GEORGE M JENKINS hold?
GEORGE M JENKINS holds: PVLA stocks.
What was GEORGE M JENKINS’s latest transaction?
GEORGE M JENKINS latest transaction was an Informative Buy of $51.72K.
What was GEORGE M JENKINS's most profitable transaction?
GEORGE M JENKINS’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is GEORGE M JENKINS's role in Palvella Therapeutics?
GEORGE M JENKINS's role in Palvella Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.